Total Payments
$109,315
2024 Payments
$4,683
Companies
36
Transactions
335
Medicare Patients
7,437
Medicare Billing
$3.4M
Payment Breakdown by Category
Other$85,571 (78.3%)
Consulting$11,500 (10.5%)
Food & Beverage$6,201 (5.7%)
Travel$5,693 (5.2%)
Education$350.18 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $85,571 | 31 | 78.3% |
| Consulting Fee | $11,500 | 4 | 10.5% |
| Food and Beverage | $6,201 | 273 | 5.7% |
| Travel and Lodging | $5,693 | 17 | 5.2% |
| Education | $350.18 | 10 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $76,391 | 87 | $0 (2022) |
| ABBVIE INC. | $28,644 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $796.46 | 46 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $796.12 | 46 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $571.48 | 28 | $0 (2019) |
| Medtronic, Inc. | $313.10 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $257.98 | 12 | $0 (2024) |
| UCB, Inc. | $149.25 | 5 | $0 (2024) |
| Microtransponder, Inc. | $130.90 | 1 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $122.45 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,683 | 40 | ABBVIE INC. ($3,954) |
| 2023 | $10,927 | 27 | ABBVIE INC. ($10,365) |
| 2022 | $21,554 | 15 | ABBVIE INC. ($14,311) |
| 2021 | $24,815 | 14 | Allergan, Inc. ($24,815) |
| 2020 | $4,464 | 15 | Allergan, Inc. ($4,332) |
| 2019 | $10,795 | 55 | Allergan Inc. ($10,129) |
| 2018 | $20,852 | 87 | Allergan Inc. ($19,807) |
| 2017 | $11,225 | 82 | Allergan Inc. ($10,065) |
All Payment Transactions
335 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: EPILEPSY | ||||||
| 11/18/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: Neurology | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $37.25 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $39.19 | General |
| Category: EPILEPSY | ||||||
| 10/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $637.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.32 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $637.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $159.15 | General |
| Category: Drug Infusion Systems | ||||||
| 08/21/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $100.21 | General |
| Category: Neuropsychiatry | ||||||
| 07/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $79.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: PSYCHIATRY | ||||||
| 06/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/22/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Neurology | ||||||
| 05/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: PSYCHIATRY | ||||||
| 04/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/19/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,275.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,603 | 125,641 | $2.0M | $910,775 |
| 2022 | 10 | 1,868 | 119,658 | $2.0M | $897,491 |
| 2021 | 10 | 2,014 | 106,029 | $1.7M | $771,011 |
| 2020 | 10 | 1,952 | 102,197 | $1.7M | $778,051 |
Total Patients
7,437
Total Services
453,525
Medicare Billing
$3.4M
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 119 | 120,903 | $1.1M | $593,028 | 53.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 835 | 3,478 | $452,140 | $204,962 | 45.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 206 | 208 | $77,168 | $27,195 | 35.2% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 64 | 170 | $76,500 | $19,203 | 25.1% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 124 | 334 | $41,750 | $18,525 | 44.4% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 90 | 278 | $125,100 | $18,100 | 14.5% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 64 | 166 | $74,700 | $15,826 | 21.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 101 | 104 | $27,560 | $13,935 | 50.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 121 | 114,500 | $1.1M | $554,044 | 52.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 820 | 3,655 | $475,150 | $196,970 | 41.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 304 | 310 | $115,010 | $45,889 | 39.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 186 | 195 | $51,675 | $23,962 | 46.4% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2022 | 67 | 169 | $76,050 | $20,877 | 27.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 126 | 324 | $40,500 | $19,402 | 47.9% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2022 | 84 | 250 | $112,500 | $17,227 | 15.3% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 65 | 158 | $71,100 | $16,572 | 23.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 82 | 84 | $8,232 | $1,862 | 22.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 13 | 13 | $1,456 | $684.32 | 47.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 101 | 102,300 | $946,275 | $495,436 | 52.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 819 | 2,092 | $271,960 | $115,074 | 42.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 328 | 336 | $124,656 | $50,501 | 40.5% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 264 | 276 | $73,140 | $34,846 | 47.6% |
| 64644 | Injection of chemical for destruction of nerve muscles on one arm or leg, 5 or more muscles | Office | 2021 | 59 | 160 | $72,000 | $19,383 | 26.9% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Office | 2021 | 104 | 293 | $36,625 | $18,398 | 50.2% |
| 64643 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2021 | 63 | 215 | $96,750 | $15,322 | 15.8% |
About Dr. Patrick O'brien, MD
Dr. Patrick O'brien, MD is a Hospice and Palliative Medicine healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356374219.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick O'brien, MD has received a total of $109,315 in payments from pharmaceutical and medical device companies, with $4,683 received in 2024. These payments were reported across 335 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($85,571).
As a Medicare-enrolled provider, O'brien has provided services to 7,437 Medicare beneficiaries, totaling 453,525 services with total Medicare billing of $3.4M. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospice and Palliative Medicine
- Other Specialties Physical Medicine & Rehabilitation
- Location Raleigh, NC
- Active Since 07/07/2006
- Last Updated 11/13/2024
- Taxonomy Code 2081H0002X
- Entity Type Individual
- NPI Number 1356374219
Products in Payments
- BOTOX (Biological) $94,256
- BOTOX (Drug) $10,064
- XARELTO (Drug) $796.46
- NUEDEXTA (Drug) $619.30
- APTIOM (Drug) $431.86
- BOTOX NEURO REHAB (Drug) $410.67
- SYNCHROMEDII (Device) $273.84
- LONHALA MAGNAIR (Drug) $215.59
- REXULTI (Drug) $174.68
- BOTOX CHRONIC MIGRAINE (Drug) $145.55
- INGREZZA (Drug) $122.45
- XIFAXAN (Drug) $112.74
- BOTOX THERAPEUTIC (Biological) $101.86
- ENTRESTO (Drug) $96.71
- Vascepa (Drug) $87.45
- VALTOCO (Drug) $85.41
- Briviact (Drug) $78.97
- NUPLAZID (Drug) $73.05
- Nayzilam (Drug) $70.28
- SAMSCA (Drug) $68.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospice and Palliative Medicine Doctors in Raleigh
Robert Rotman, M.d, M.D
Hospice and Palliative Medicine — Payments: $96.00
Hospice and Palliative Medicine $96.00
Camila Diaz, M.d, M.D
Hospice and Palliative Medicine — Payments: $18.52
Hospice and Palliative Medicine $18.52
Dr. Debra Blue, Md, MD
Hospice and Palliative Medicine
Hospice and Palliative Medicine
Dr. Stephen Marsh, M. D, M. D
Hospice and Palliative Medicine
Hospice and Palliative Medicine
Dr. Anthony Carraway, M. D, M. D
Hospice and Palliative Medicine
Hospice and Palliative Medicine